Questions raised of cold and flu formulations

New research has raised questions over the formulation of cold and flu products, with findings indicating that suggested doses could accidentally lead to twice the recommended intake of phenylephrine.

The research published today in the New England Journal of Medicine was by a University of Auckland academic and researchers from AFT Pharmaceuticals.